¼¼°èÀÇ ¼¼Æ÷ µ¿°áº¸Á¸ ½ÃÀå º¸°í¼­(2025³â)
Cell Cryopreservation Global Market Report 2025
»óǰÄÚµå : 1703091
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,344,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,170,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,996,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼Æ÷ µ¿°áº¸Á¸ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ¿¬Æò±Õ 23.9%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇϸç 2029³â¿¡´Â 370¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ü¿Ü¼öÁ¤(IVF) ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Àå±â ÀÌ½Ä ½Ã¼úÀÇ ¹ßÀü, ¹ÙÀÌ¿À ¹ðÅ· Ȱµ¿ÀÇ È®´ë, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¤ºÎÀÇ Àû±ØÀûÀÎ ³ë·Â°ú ÀÚ±Ý Áö¿ø µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ³Ãµ¿ º¸Á¸ ±â¼úÀÇ ¹ßÀü, mRNA ¹é½ÅÀÇ º¸Á¸ ¹× ¿î¼ÛÀÇ ¹ßÀü, ³Ãµ¿ º¸È£Á¦ ¹× ³Ãµ¿ ±â¼úÀÇ ¹ßÀü, °³ÀÎ ¸ÂÃãÇü ÀÇ·á Æ®·»µå Áõ°¡, Áٱ⼼Æ÷ ¿¬±¸ÀÇ ¹ßÀü µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

¼¼Æ÷ µ¿°áº¸Á¸ ½ÃÀåÀÇ ¼ºÀåÀº Àå±â ÀÌ½Ä ¼ö¼ú Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àå±â À̽ÄÀº ¼Õ»óµÈ Àå±â³ª ±â´É Àå¾Ö°¡ ÀÖ´Â Àå±â¸¦ ±âÁõÀڷκÎÅÍ ¾òÀº °Ç°­ÇÑ Àå±â·Î ´ëüÇÏ´Â °ÍÀ¸·Î, À¯ÀüÀû ÀÌ»ó, °¨¿°, ¿Ü»ó, ¸¸¼º Áúȯ µî ´Ù¾çÇÑ ¿øÀÎÀ¸·Î ÀÎÇÑ Àå±â ºÎÀü µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Áõ°¡ Ãß¼¼¿¡ ÀÖ½À´Ï´Ù. Àå±â À̽Ŀ¡¼­ ¼¼Æ÷ µ¿°áº¸Á¸Àº Àå±â ¼¼Æ÷¸¦ µ¿°áº¸Á¸ÇÏ¿© ÇâÈÄ »ç¿ëÀ» À§ÇØ ±× »ýÁ¸·ÂÀ» À¯ÁöÇϰí, ÀÌ½Ä ¼º°ø·üÀ» ³ôÀ̰í, ¸é¿ª °ÅºÎ¹ÝÀÀÀ» °¨¼Ò½ÃŰ´Â Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù Health Resources and Services AdministrationÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2023³â Àå±â À̽ÄÀÌ ÀÌÀüº¸´Ù Å©°Ô Áõ°¡ÇÏ¿© ¼¼Æ÷ µ¿°áº¸Á¸¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ´Â Àå±â ÀÌ½Ä Áõ°¡ Ãß¼¼°¡ µÎµå·¯Áö°Ô ³ªÅ¸³µ½À´Ï´Ù.

¼¼Æ÷ µ¿°áº¸Á¸ ½ÃÀåÀÇ °¢ ¾÷üµéÀº ÁøÈ­ÇÏ´Â °í°´ ´ÏÁî¿¡ ´ëÀÀÇϱâ À§ÇØ Ã·´Ü µ¿°áº¸Á¸ ¹èÁö ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. µ¿°áº¸Á¸¹èÁö ¼Ö·ç¼ÇÀº ¼¼Æ÷³ª Á¶Á÷À» ÃÊÀú¿Â¿¡¼­ µ¿°áÇϴ Ư¼öÇÑ Á¦Á¦À̸ç, »ýÁ¸ ´É·Â°ú ±â´É¼ºÀ» À¯ÁöÇÑ Ã¤ Àå±â º¸Á¸ ¹× ¿î¼ÛÀÌ °¡´ÉÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡ º»»ç¸¦ µÐ ¼¼Æ÷ Ä¡·á µµ±¸ ¹× ±â¼úÀ» Á¦°øÇÏ´Â Pluristyx Inc.´Â ÃÖ±Ù Áٱ⼼Æ÷ Ä¡·áÁ¦ °³¹ßÀ» °¡¼ÓÈ­Çϱâ À§ÇØ °í¾ÈµÈ µ¶ÀÚÀûÀÎ µ¿°áº¸Á¸¹èÁö ¼Ö·ç¼ÇÀÎ PluriFreeze¸¦ Ãâ½ÃÇß½À´Ï´Ù.(iPSC)ÀÇ ¼ºÀåÀ» Áö¿øÇϵµ·Ï Á¶Á¤µÇ¾úÀ¸¸ç, ƯÈ÷ Áٱ⼼Æ÷ Ä¡·áÁ¦ ¿¬±¸ ¹× »ó¾÷È­¿¡¼­ iPSC Ä¡·áÁ¦ °³¹ßÀÇ È¿À²¼º°ú ǰÁúÀ» Çâ»ó½ÃŰ´Â »õ·Î¿î Á¢±Ù¹ýÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cell cryopreservation involves cooling cells to sub-zero temperatures, typically in liquid nitrogen at -196°C, to preserve them. This process stops all biological activity and metabolism, enabling cells to be stored for extended periods without deterioration. Cryoprotective agents are essential to prevent ice crystal formation, which could harm cell structures during freezing and thawing.

The primary products of cell cryopreservation include cell freezing media, equipment, and consumables. Equipment comprises specialized tools such as controlled-rate freezing apparatuses or isopropanol chambers designed to freeze cells at specific rates. This technology finds applications in preserving various cell types such as hepatocytes, stem cells, oocytes, embryotic cells, sperm cells, among others. These products reach end-users through channels such as biopharmaceutical and pharmaceutical companies, research institutes, Biobanks, in vitro fertilization (IVF) clinics, and similar entities.

The cell cryopreservation market research report is one of a series of new reports from The Business Research Company that provides cell cryopreservation market statistics, including the cell cryopreservation industry global market size, regional shares, competitors with cell cryopreservation market share, detailed cell cryopreservation market segments, market trends, and opportunities, and any further data you may need to thrive in the cell cryopreservation industry. These cell cryopreservation market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell cryopreservation market size has grown exponentially in recent years. It will grow from $12.65 billion in 2024 to $15.72 billion in 2025 at a compound annual growth rate (CAGR) of 24.3%. The growth in the historic period can be attributed to increasing demand for cell-based therapies, rise in biomedical research, growing need for organ transplantation, rise in R&D activities for cell based therapies and increasing use of cryopreserved cell.

The cell cryopreservation market size is expected to see exponential growth in the next few years. It will grow to $37.01 billion in 2029 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to rising demand for in vitro fertilization (IVF) procedures, advancement in organ transplantation procedures, expansion of biobanking activities, rising incidence of chronic diseases and positive government initiatives and funding. Major trends in the forecast period include advancements in cryopreservation techniques, advancements in MRNA vaccine storage and transportation, advancements in cryoprotectants and freezing techniques, growing trend towards personalized medicine and advancements in stem cell research.

The growth of the cell cryopreservation market is anticipated to be driven by the increasing number of organ transplantation procedures. Organ transplantation involves replacing damaged or failing organs with healthy ones from donors, a procedure on the rise due to factors such as organ failure from various causes such as hereditary abnormalities, infections, traumas, and chronic diseases. In the context of organ transplantation, cell cryopreservation plays a vital role by freezing and storing cells from organs, preserving their viability for future use, improving graft success rates, and reducing immune rejection. For instance, data from the Health Resources and Services Administration in January 2024 showed a significant increase in organ transplants performed in 2023 compared to previous years, highlighting the upward trend in organ transplantation that fuels the demand for cell cryopreservation.

Companies in the cell cryopreservation market are focusing on developing advanced cryopreservation medium solutions to meet evolving customer needs. Cryopreservation medium solutions are specialized formulations that freeze cells or tissues at ultra-low temperatures, enabling long-term storage and transport while maintaining their viability and functionality. For example, Pluristyx Inc., a US-based provider of tools and technologies for cellular therapies, recently introduced PluriFreeze, a proprietary cryopreservation medium solution designed to accelerate the development of stem cell therapies. PluriFreeze is specifically tailored to support the growth of induced pluripotent stem cells (iPSCs), offering a novel approach to enhance the efficiency and quality of iPSC therapy development, particularly in stem cell therapy research and commercialization.

In January 2022, Cryoport, Inc., a management consulting services firm located in the US, joined forces with Cell Matters S.A. to offer comprehensive cryopreservation solutions for both autologous and allogeneic leukapheresis-based cell therapies. This collaboration aims to provide the life sciences sector with complete, end-to-end cryopreservation services, improving the consistency and quality of therapies derived from leukapheresis for both types of cell therapies. Cell Matters S.A., based in Belgium, specializes in cryobiology, cell therapy production, and cryopreservation techniques.

Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., BioLife Solutions Inc, Nkarta Inc., Tn-Sanso Corporation, Coya Therapeutics, FUJIFILM Irvine Scientific, Artiva Biotherapeutics, Acorn Biolabs Inc., ThermoGenesis Holdings Inc., Evia Bio Inc., Wideblue Limited, Akron Biotech, Captivate Bio LLC, Pluristyx Inc., CryoCrate LLC, PanTHERA CryoSolutions, ParaTechs Corporation, Plus Therapeutics, X-Therma Inc., Protein Technologies Limited

North America was the largest region in the cell cryopreservation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell cryopreservation market consists of sales of cryoprotectants, freezing containers, and cryogenic storage systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Cryopreservation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell cryopreservation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cell cryopreservation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell cryopreservation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cell Cryopreservation Market Characteristics

3. Cell Cryopreservation Market Trends And Strategies

4. Cell Cryopreservation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell Cryopreservation Growth Analysis And Strategic Analysis Framework

6. Cell Cryopreservation Market Segmentation

7. Cell Cryopreservation Market Regional And Country Analysis

8. Asia-Pacific Cell Cryopreservation Market

9. China Cell Cryopreservation Market

10. India Cell Cryopreservation Market

11. Japan Cell Cryopreservation Market

12. Australia Cell Cryopreservation Market

13. Indonesia Cell Cryopreservation Market

14. South Korea Cell Cryopreservation Market

15. Western Europe Cell Cryopreservation Market

16. UK Cell Cryopreservation Market

17. Germany Cell Cryopreservation Market

18. France Cell Cryopreservation Market

19. Italy Cell Cryopreservation Market

20. Spain Cell Cryopreservation Market

21. Eastern Europe Cell Cryopreservation Market

22. Russia Cell Cryopreservation Market

23. North America Cell Cryopreservation Market

24. USA Cell Cryopreservation Market

25. Canada Cell Cryopreservation Market

26. South America Cell Cryopreservation Market

27. Brazil Cell Cryopreservation Market

28. Middle East Cell Cryopreservation Market

29. Africa Cell Cryopreservation Market

30. Cell Cryopreservation Market Competitive Landscape And Company Profiles

31. Cell Cryopreservation Market Other Major And Innovative Companies

32. Global Cell Cryopreservation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Cryopreservation Market

34. Recent Developments In The Cell Cryopreservation Market

35. Cell Cryopreservation Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â